Damon E. Houghton, M.D., M.S.

  1. Hematologist
  2. Vascular Medicine Specialist
  1. McBane RD 2nd, Murphree DH, Liedl D, Lopez-Jimenez F, Arruda-Olson A, Scott CG, Prodduturi N, Nowakowski SE, Rooke TW, Casanegra AI, Wysokinski WE, Houghton DE, Muthusamy K, Wennberg PW. Artificial intelligence of arterial Doppler waveforms to predict major adverse outcomes among patients with diabetes mellitus. J Vasc Surg. 2024 Jul; 80 (1):251-259.e3 Epub 2024 Feb 28
    View PubMed
  2. Ghorbanzadeh A, Abud A, Liedl D, Rooke T, Wennberg P, Wysokinski W, McBane R, Houghton DE. Reduced calf muscle pump function is not explained by handgrip strength measurements. J Vasc Surg Venous Lymphat Disord. 2024 Jul; 12 (4):101869 Epub 2024 Mar 07
    View PubMed
  3. Sykora D, Churchill RA, Hodge DO, Callori S, Houghton DE, McBane RD, Wysokinski WE. Pulmonary vein thrombosis: Clinical presentation and outcomes. Thromb Res. 2024 Jul; 239:109028 Epub 2024 May 10
    View PubMed
  4. McBane RD, Liedl D, Wysokinski W, Wennberg PW, Casanegra AI, Ghorbanzadeh A, Arruda-Olson A, Scott CG, Lee AT, Ahmed A, Rooke TW, Houghton DE. Calf rEF: Impact of Calf Muscle Pump Dysfunction With Reduced Ejection Fraction on All-Cause Mortality. Mayo Clin Proc. 2024 Jun; 99 (6):902-912 Epub 2024 Apr 24
    View PubMed
  5. McBane RD 2nd, Loprinzi CL, Zemla T, Tafur A, Sanfilippo K, Liu JJ, Garcia DA, Heun J, Gundabolu K, Onitilo AA, Perepu U, Drescher MR, Henkin S, Houghton D, Ashrani A, Billett H, McCue SA, Lee MK, Le-Rademacher JG, Wysokinski WE, EVE trial investigators. Extending venous thromboembolism secondary prevention with apixaban in cancer patients. The EVE trial. J Thromb Haemost. 2024 Jun; 22 (6):1704-1714 Epub 2024 Mar 25
    View PubMed
  6. Wysokinski WE, Meverden RA, Lopez-Jimenez F, Harmon D Jr., Medina Inojosa BJ, Baez Suarez A, Liu K, Medina Inojosa JR, Casanegra AI, McBane RD, Houghton DE. Electrocardiogram Signal Analysis With a Machine Learning Model Predicts the Presence of Pulmonary Embolism With Accuracy Dependent on Embolism Burden Mayo Clinic Proceedings: Digital Health. 2024.
  7. Kusne Y, Ghorbanzadeh A, Dulau-Florea A, Shalhoub R, Alcedo PE, Nghiem K, Ferrada MA, Hines A, Quinn KA, Panicker SR, Ombrello AK, Reichard K, Darden I, Goodspeed W, Durrani J, Wilson L, Olteanu H, Lasho T, Kastner DL, Warrington KJ, Mangaonkar A, Go RS, Braylan RC, Beck DB, Patnaik MM, Young NS, Calvo KR, Casanegra AI, Grayson PC, Koster MJ, Wu CO, Kanthi Y, Patel BA, Houghton DE, Groarke EM. Venous and arterial thrombosis in patients with VEXAS syndrome. Blood. 2024 May 23; 143 (21):2190-2200
    View PubMed
  8. Kurmann RD, Klarich KW, Wysokinska E, Houghton D, Kaminska A, Patrzalek P, Hodge D, Wysokinski WE. Echocardiographic findings in cancer-associated non-bacterial thrombotic endocarditis. Clinical series of 111 patients from single institution. Eur Heart J Cardiovasc Imaging. 2024 Apr 25 [Epub ahead of print]
    View PubMed
  9. Vlazny DT, Houghton DE. Impact of vascular medicine specialists on inpatient utilization and management of inferior vena cava filters. Vasc Med. 2024 Apr; 29 (2):123-124 Epub 2024 Feb 09
    View PubMed
  10. Patrzalek P, Wysokinski WE, Kurmann RD, Houghton D, Hodge D, Kuczmik W, Klarich KW, Wysokinska EM. Cancer-associated non-bacterial thrombotic endocarditis-Clinical series from a single institution. Am J Hematol. 2024 Apr; 99 (4):596-605 Epub 2024 Feb 13
    View PubMed
  11. Houghton DE, Casanegra AI, Wysokinski WE, Padrnos LJ, Wysokinska E, Pruthi R, Heaton H, Sridharan M, McBane RD, Shah S. COVID-19 infection and risk stratification for pulmonary embolism: Identifying optimal D-dimer thresholds. Thromb Res 2024 Mar; 235:8-10 Epub 2024 Jan 12
    View PubMed
  12. McBane RD 2nd, Murphree DH, Liedl D, Lopez-Jimenez F, Attia IZ, Arruda-Olson AM, Scott CG, Prodduturi N, Nowakowski SE, Rooke TW, Casanegra AI, Wysokinski WE, Houghton DE, Bjarnason H, Wennberg PW. Artificial Intelligence of Arterial Doppler Waveforms to Predict Major Adverse Outcomes Among Patients Evaluated for Peripheral Artery Disease. J Am Heart Assoc. 2024 Feb 6; 13 (3):e031880 Epub 2024 Jan 19
    View PubMed
  13. Brunton N, McBane R, Casanegra AI, Houghton DE, Balanescu DV, Ahmad S, Caples S, Motiei A, Henkin S. Risk Stratification and Management of Intermediate-Risk Acute Pulmonary Embolism. J Clin Med. 2024 Jan 2; 13 (1) Epub 2024 Jan 02
    View PubMed
  14. Ghorbanzadeh A, Houghton D. Images in Vascular Medicine: A case of recurrent hemorrhagic bullae from enoxaparin and then fondaparinux. Vasc Med. 2023 Dec; 28 (6):616-617 Epub 2023 Sept 12
    View PubMed
  15. Middeldorp S, Nieuwlaat R, Baumann Kreuziger L, Coppens M, Houghton D, James AH, Lang E, Moll S, Myers T, Bhatt M, Chai-Adisaksopha C, Colunga-Lozano LE, Karam SG, Zhang Y, Wiercioch W, Schunemann HJ, Iorio A. American Society of Hematology 2023 guidelines for management of venous thromboembolism: thrombophilia testing. Blood Adv. 2023 Nov 28; 7 (22):7101-7138
    View PubMed
  16. Ghorbanzadeh A, Houghton D, Bendel E. An unusual cutaneous reaction to anticoagulation: a case of recurrent hemorrhagic bullae from enoxaparin and then fondaparinux. Vascular Medicine. 2023; 28(5):NP9.
  17. Gaddh M, Scott D, Wysokinski WE, McBane RD, Casanegra AI, Baumann Kreuziger L, Houghton DE. Comparison of Venous Thromboembolism Outcomes after COVID-19 and Influenza Vaccinations. TH Open. 2023 Oct; 7 (4):e303-e308 Epub 2023 Dec 04
    View PubMed
  18. Scott DM, Abud A, Amor M, Saemi A, Baumann Kreuziger L, Houghton D. Natural Language Processing tool accurately identifies acute venous thromboembolism. Thromb Res 2023 Sep; 229:252-254 Epub 2023 Aug 12
    View PubMed
  19. Riaz IB, Fuentes H, Deng Y, Naqvi SAA, Yao X, Sangaralingham LR, Houghton DE, Padrnos LJ, Shamoun FE, Wysokinski WE, McBane RD 2nd. Comparative Effectiveness of Anticoagulants in Patients With Cancer-Associated Thrombosis. JAMA Netw Open. 2023 Jul 3; 6 (7):e2325283 Epub 2023 July 03
    View PubMed
  20. McBane Ii RD, Vlazny DT, Houghton D, Casanegra AI, Froehling D, Daniels P, Riaz IB, Hodge DO, Wysokinski WE. Survival Implications of Thrombus Recurrence or Bleeding in Cancer Patients Receiving Anticoagulation for Venous Thromboembolism Treatment. Thromb Haemost. 2023 May; 123 (5):535-544 Epub 2022 Dec 27
    View PubMed
  21. Houghton DE, Wysokinski WE, Padrnos LJ, Shah S, Wysokinska E, Pruthi R, Ghorbanzadeh A, Ashrani A, Sridharan M, McBane RD, Padmanabhan A, Casanegra AI. Venous thromboembolism after COVID-19 vaccination in patients with thrombophilia. Am J Hematol. 2023 Apr; 98 (4):566-570 Epub 2023 Jan 28
    View PubMed
  22. Houghton DE, Ashrani A, Liedl D, Mehta RA, Hodge DO, Rooke T, Wennberg P, Wysokinski W, McBane R. Reduced calf pump function and proximal deep vein incompetence are predictors for ipsilateral deep vein thrombosis. Vasc Med 2023 Feb; 28 (1):57-58 Epub 2022 Sept 30
    View PubMed
  23. Wysokinska EM, Houghton DE, Vlazny DT, Ashrani AA, Froehling DA, Meverden R, Hodge DO, Peterson LG, McBane RD, Wysokinski WE, Casanegra AI. Incidental pulmonary embolism in cancer and noncancer patients: Prospective cohort study. Eur J Haematol. 2023 Jan; 110 (1):88-98 Epub 2022 Oct 21
    View PubMed
  24. Wysokinski WE, Houghton DE, Vlazny DT, Ashrani AA, Froehling DA, Kamath PS, Meverden RA, Hodge DO, Peterson LG, Lang TR, McBane RD, Casanegra AI. Influence of primary cancer site on clinical outcomes of anticoagulation for associated venous thromboembolism. Thromb Res. 2023 Jan; 221:37-44 Epub 2022 Nov 15
    View PubMed
  25. Chaudhary R, Singh A, Chaudhary R, Bashline M, Houghton DE, Rabinstein A, Adamski J, Arndt R, Ou NN, Rudis MI, Brown CS, Wieruszewski ED, Wanek M, Brinkman NJ, Linderbaum JA, Sorenson MA, Atkinson JL, Thompson KM, Aiyer AN, McBane RD 2nd. Evaluation of Direct Oral Anticoagulant Reversal Agents in Intracranial Hemorrhage: A Systematic Review and Meta-analysis. JAMA Netw Open. 2022 Nov 1; 5 (11):e2240145 Epub 2022 Nov 01
    View PubMed
  26. Daniels P, Vlazny D, Meverden R, Bartlett M, Hesley G, Lekah A, Macedo T, Wysokinski WE, Houghton DE. Popliteal cysts are not a risk factor for lower extremity deep vein thrombosis. J Thromb Thrombolysis. 2022 Oct; 54 (3):492-499 Epub 2022 Aug 06
    View PubMed
  27. McBane RD 2nd, Murphree DH, Liedl D, Lopez-Jimenez F, Attia IZ, Arruda-Olson A, Scott CG, Prodduturi N, Nowakowski SE, Rooke TW, Casanegra AI, Wysokinski WE, Swanson KE, Houghton DE, Bjarnason H, Wennberg PW. Artificial intelligence for the evaluation of peripheral artery disease using arterial Doppler waveforms to predict abnormal ankle-brachial index. Vasc Med. 2022 Aug; 27 (4):333-342 Epub 2022 May 10
    View PubMed
  28. Hirao-Try Y, Vlazny DT, Meverden R, Houghton DE, Casanegra AI, Froehling DA, Hodge DO, Peterson LG, McBane RD, Wysokinski WE. Single versus multiple and incidental versus symptomatic subsegmental pulmonary embolism: clinical characteristics and outcome. J Thromb Thrombolysis. 2022 Jul; 54(1):82-90. Epub 2022 Jan 07.
    View PubMed
  29. Houghton DE, Wysokinski W, Casanegra AI, Padrnos LJ, Shah S, Wysokinska E, Pruthi R, Ashrani A, Sridharan M, Baumann-Kreuziger L, McBane R, Padmanabhan A. Risk of venous thromboembolism after COVID-19 vaccination. J Thromb Haemost. 2022 Jul; 20 (7):1638-1644 Epub 2022 Apr 20
    View PubMed
  30. Sridharan M, D Navitskas S, M Kock E, E Houghton D, Houghton D, Heikal NM, M Heikal N, Chen D, Pruthi R, K Pruthi R. Evaluation of soluble fibrin monomer complex in patients in SARS-CoV-2 COVID-19 infection-associated coagulopathy. Eur J Haematol. 2022 Apr; 108 (4):319-326 Epub 2022 Jan 10
    View PubMed
  31. Quintero-Martinez JA, Wysokinski WE, Cordova-Madera SN, Mogollon RJ, Garcia-Arango M, Vlazny DT, Houghton DE, Casanegra AI, Villarraga HR. Pulmonary artery capacitance and pulmonary vascular resistance as prognostic indicators in acute pulmonary embolism. Eur Heart J Open. 2022 Mar; 2 (2):oeac007 Epub 2022 Feb 23
    View PubMed
  32. Houghton DE, Vlazny DT, Casanegra AI, Brunton N, Froehling DA, Meverden RA, Hodge DO, Peterson LG, McBane RD, Wysokinski WE. Bleeding in Patients With Gastrointestinal Cancer Compared With Nongastrointestinal Cancer Treated With Apixaban, Rivaroxaban, or Enoxaparin for Acute Venous Thromboembolism. Mayo Clin Proc. 2021 Nov; 96(11):2793-2805. Epub 2021 Aug 20.
    View PubMed
  33. Pasha AK, McBane RD, Chaudhary R, Padrnos LJ, Wysokinska E, Pruthi R, Ashrani A, Daniels P, Sridharan M, Wysokinski WE, Houghton DE. Timing of venous thromboembolism diagnosis in hospitalized and non-hospitalized patients with COVID-19. Thromb Res. 2021 Nov; 207:150-157 Epub 2021 Oct 07
    View PubMed
  34. Augustine MR, Knavel Koepsel EM, Peterson LG, Rupkalvis L, Comstock A, McPhail I, McBane RD, Bjarnason H, Houghton DE. Evaluation of Changing Vena Cava Filter Use and Inpatient Hospital Mortality from 2016-2019: A Single-Institution Quality Improvement Project. Mayo Clin Proc Innov Qual Outcomes. 2021 Oct; 5 (5):851-858 Epub 2021 Sept 03
    View PubMed
  35. Gangaraju R, Koh I, Irvin MR, Lange L, Houghton DE, Herrera DA, Safford M, Cushman M, Bhatia S, Zakai NA. Peripheral Blood Cytopenia and Risk of Cardiovascular Disease and Mortality. J Am Heart Assoc. 2021 Sep 21; 10 (18):e020809 Epub 2021 Sept 13
    View PubMed
  36. Vlazny DT, Pasha AK, Kuczmik W, Wysokinski WE, Bartlett M, Houghton D, Casanegra AI, Daniels P, Froehling DA, White LJ, Hodge DO, McBane RD 2nd. Outcome of anticoagulation in isolated distal deep vein thrombosis compared to proximal deep venous thrombosis. J Thromb Haemost. 2021 Sep; 19 (9):2206-2215 Epub 2021 July 21
    View PubMed
  37. Houghton DE, Billett HH, Gaddh M, Onadeko O, George G, Wang TF, Oo TH, Feng M, Dasgupta M, Jaglal M, Streiff MB, Simpson P, Gali R, Baumann Kreuziger L. Risk of pulmonary emboli after removal of an upper extremity central catheter associated with a deep vein thrombosis. Blood Adv. 2021 Jul 27; 5 (14):2807-2812
    View PubMed
  38. Chaudhary R, Padrnos L, Wysokinska E, Pruthi R, Misra S, Sridharan M, Wysokinski W, McBane RD 2nd, Houghton DE. Macrovascular Thrombotic Events in a Mayo Clinic Enterprise-Wide Sample of Hospitalized COVID-19-Positive Compared With COVID-19-Negative Patients. Mayo Clin Proc. 2021 Jul; 96 (7):1718-1726 Epub 2021 May 04
    View PubMed
  39. Chaudhary R, Loganathan D, Vlazny DT, Casanegra AI, Houghton DE, Froehling DA, Peterson LG, Hodge DO, McBane RD 2nd, Wysokinski WE. Demographics and Clinical Outcomes in Patients Older Than 75 Years Treated for Acute Venous Thromboembolism. Am J Ther 2021 Jun 11; 29 (1):e151-e153 Epub 2021 June 11
    View PubMed
  40. Houghton DE, Ashrani A, Liedl D, Mehta RA, Hodge DO, Rooke T, Wennberg P, Wysokinski W, McBane R. Reduced calf muscle pump function is a risk factor for venous thromboembolism: a population-based cohort study. Blood. 2021 Jun 10; 137 (23):3284-3290
    View PubMed
  41. Baumann Kreuziger L, Gaddh M, Onadeko O, George G, Wang TF, Oo TH, Jaglal M, Houghton DE, Streiff MB, Gali R, Feng M, Simpson P, Billett HH. Treatment of catheter-related thrombosis in patients with hematologic malignancies: A Venous thromboEmbolism Network U.S. retrospective cohort study. Thromb Res. 2021 Jun; 202:155-161 Epub 2021 Apr 06
    View PubMed
  42. Pasha AK, Kuczmik W, Wysokinski WE, Casanegra AI, Houghton D, Vlazny DT, Mertzig A, Hirao-Try Y, White L, Hodge D, McBane Ii R. Calf vein thrombosis outcomes comparing patients with and without cancer. J Thromb Thrombolysis. 2021 May; 51 (4):1059-1066 Epub 2021 Feb 04
    View PubMed
  43. Brunton NE, Wysokinski WE, Hodge DO, Vlazny DT, Houghton DE, Casanegra AI. Delayed anticoagulation in venous thromboembolism: Reasons and associated outcomes. Res Pract Thromb Haemost. 2021 May; 5 (4):e12500 Epub 2021 Apr 07
    View PubMed
  44. Kuczmik W, Wysokinski WE, Macedo T, Froehling D, Daniels P, Casanegra A, Houghton D, Vlazny D, Meverden R, Lang T, White L, Hodge D, McBane RD 2nd. Calf Vein Thrombosis Outcomes Comparing Anticoagulation and Serial Ultrasound Imaging Management Strategies. Mayo Clin Proc. 2021 May; 96 (5):1184-1192 Epub 2021 Apr 09
    View PubMed
  45. Chaudhary R, Garg J, Houghton DE, Murad MH, Kondur A, Chaudhary R, Wysokinski WE, McBane RD 2nd. Thromboinflammatory Biomarkers in COVID-19: Systematic Review and Meta-analysis of 17,052 Patients. Mayo Clin Proc Innov Qual Outcomes. 2021 Apr; 5 (2):388-402 Epub 2021 Feb 08
    View PubMed
  46. Trung Tran T, Bjarnason H, McDonald J, Skaga NO, Houghton DE, Kim B, Stavem K, Klow NE. Prophylactic placement of inferior vena cava filters and the risk of death or venous thromboembolism in severe trauma patients: a retrospective study comparing two hospitals with different approaches. Acta Radiol Open. 2021 Mar; 10 (3):2058460121999345 Epub 2021 Mar 09
    View PubMed
  47. Kuczmik W, Wysokinski WE, Hesley GK, Vlazny DT, Houghton DE, Swanson KE, Casanegra AI, Hodge D, White L, McBane RD 2nd. Calf Vein Thrombosis Comparison of Outcomes for Axial and Muscular Venous Thrombosis. Thromb Haemost. 2021 Feb; 121 (2):216-223 Epub 2020 Aug 22
    View PubMed
  48. Tran TT, Bjarnason H, McDonald J, Goss B, Kim B, Houghton DE, Stavem K, Klow NE. Does prophylactic inferior vena cava filter reduce the hazard of pulmonary embolism and mortality in severe trauma? A single center retrospective comparative study. Eur J Radiol Open. 2021; 8:100299 Epub 2020 Dec 10
    View PubMed
  49. Halkar M, Medina Inojosa J, Liedl D, Wysokinski W, Houghton DE, Wennberg PW, Lin G, Kane G, Fischer K, Rooke TW, Saadiq R, Bonikowske A, McBane RD 2nd. Calf muscle pump function as a predictor of all-cause mortality. Vasc Med. 2020 Dec; 25 (6):519-526 Epub 2020 Sept 25
    View PubMed
  50. McBane RD 2nd, Torres Roldan VD, Niven AS, Pruthi RK, Franco PM, Linderbaum JA, Casanegra AI, Oyen LJ, Houghton DE, Marshall AL, Ou NN, Siegel JL, Wysokinski WE, Padrnos LJ, Rivera CE, Flo GL, Shamoun FE, Silvers SM, Nayfeh T, Urtecho M, Shah S, Benkhadra R, Saadi SM, Firwana M, Jawaid T, Amin M, Prokop LJ, Murad MH. Anticoagulation in COVID-19: A Systematic Review, Meta-analysis, and Rapid Guidance From Mayo Clinic. Mayo Clin Proc. 2020 Nov; 95 (11):2467-2486 Epub 2020 Aug 31
    View PubMed
  51. Wysokinski WE, Froehling DA, Houghton DE, McBane RD, Vlazny DT, Bott-Kitslaar DM, Kuczmik W, Sutkowska K, Bator K, Hodge DO, Peterson LG, Casanegra AI. Effectiveness and safety of apixaban and rivaroxaban for acute venous thromboembolism therapy in patients with extremes in bodyweight. Eur J Haematol. 2020 Oct; 105 (4):484-494 Epub 2020 July 27
    View PubMed
  52. Pawlowski C, Wagner T, Puranik A, Murugadoss K, Loscalzo L, Venkatakrishnan AJ, Pruthi RK, Houghton DE, O'Horo JC, Morice WG 2nd, Williams AW, Gores GJ, Halamka J, Badley AD, Barnathan ES, Makimura H, Khan N, Soundararajan V. Inference from longitudinal laboratory tests characterizes temporal evolution of COVID-19-associated coagulopathy (CAC). Elife. 2020 Aug 17; 9
    View PubMed
  53. Houghton DE, Casanegra AI, Peterson L, Cochuyt J, Hodge DO, Vlazny D, McBane RD, Froehling D, Wysokinski WE. Treatment of upper extremity deep vein thrombosis with apixaban and rivaroxaban. Am J Hematol. 2020 Jul; 95 (7):817-823 Epub 2020 Apr 20
    View PubMed
  54. Cambron JC, Saba ES, McBane RD, Casanegra AI, Villarraga HR, Houghton DE, Vlazny DT, Froehling D, Hodge D, Peterson LG, Bott-Kitslaar DM, Wysokinski WE. Adverse Events and Mortality in Anticoagulated Patients with Different Categories of Pulmonary Embolism. Mayo Clin Proc Innov Qual Outcomes. 2020 Jun; 4 (3):249-258 Epub 2020 June 05
    View PubMed
  55. Halkar M, Ward R, Koepsel EK, Bjarnason H, McBane R, Houghton D. Prevalence, Indications, and Outcomes of Stacked Vena Cava Filters. Cardiovasc Intervent Radiol 2020 May; 43 (5):800-802 Epub 2020 Mar 06
    View PubMed
  56. Chaudhary R, Kirchoff R, Kingsley T, Newman JS, Houghton DE, McBane RD 2nd. Venous Thromboembolism Prophylaxis: Need for Continuous Assessment Due to Changes in Risk During the Same Hospitalization. Mayo Clin Proc Innov Qual Outcomes. 2020 Apr; 4 (2):170-175 Epub 2020 Mar 18
    View PubMed
  57. Houghton DE, Koh I, Ellis A, Key NS, Douce DR, Howard G, Cushman M, Safford M, Zakai NA. Hemoglobin levels and coronary heart disease risk by age, race, and sex in the reasons for geographic and racial differences in stroke study (REGARDS). Am J Hematol. 2020 Mar; 95 (3):258-266 Epub 2019 Dec 22
    View PubMed
  58. Houghton DE, Lekah A, Macedo TA, Hodge D, Saadiq RA, Little Y, Casanegra AI, McBane RD, Wysokinski WE. Resolution of acute lower extremity deep vein thrombosis with rivaroxaban compared to warfarin. J Thromb Thrombolysis. 2020 Feb; 49 (2):199-205
    View PubMed
  59. McBane RD 2nd, Loprinzi CL, Ashrani A, Lenz CJ, Houghton D, Zemla T, Le-Rademacher JG, Wysokinski WE. Extending venous thromboembolism secondary prevention with apixaban in cancer patients: The EVE trial. Eur J Haematol. 2020 Feb; 104 (2):88-96 Epub 2019 Nov 11
    View PubMed
  60. McBane RD 2nd, Wysokinski WE, Le-Rademacher JG, Zemla T, Ashrani A, Tafur A, Perepu U, Anderson D, Gundabolu K, Kuzma C, Perez Botero J, Leon Ferre RA, Henkin S, Lenz CJ, Houghton DE, Vishnu P, Loprinzi CL. Apixaban and dalteparin in active malignancy-associated venous thromboembolism: The ADAM VTE trial. J Thromb Haemost. 2020 Feb; 18 (2):411-421 Epub 2019 Nov 28
    View PubMed
  61. Cambron ,, Saba ,, McBane RD, Casanegra A, Villarraga HR, Houghton D, Vlazny DT, Froehling DA, Hodge DO, Peterson ,, Bott DM. Pulmonary embolism categories do not predict adverse events or mortality in anticoagulated patients CHEST. 2020.
  62. Chaudhary R, Kirchoff R, Kingsley T, Newman J, Houghton D, McBane R. Venous Thromboembolism Prophylaxis: Need of Continuous Assessment due to Changes in Risk during the Same Hospitalization Mayo Clinic Proceedings: Innovations, Quality & Outcomes. 2019.
  63. Wysokinski WE, Houghton DE, Casanegra AI, Vlazny DT, Bott-Kitslaar DM, Froehling DA, Hodge DO, Peterson LG, Mcbane RD. Comparison of apixaban to rivaroxaban and enoxaparin in acute cancer-associated venous thromboembolism. Am J Hematol. 2019 Nov; 94 (11):1185-1192 Epub 2019 Aug 19
    View PubMed
  64. Bott-Kitslaar DM, McBane RD, Casanegra AI, Houghton DE, Froehling DA, Vlazny DT, Ashrani AA, Hodge DO, Vargas ER, Bartlett MA, Saadiq RA, Daniels PR, Shields RC, Lenz CJ, Lang TR, Wysokinski WE. Apixaban and Rivaroxaban in Patients With Acute Venous Thromboembolism. Mayo Clin Proc. 2019 Jul; 94 (7):1242-1252 Epub 2019 Feb 06
    View PubMed
  65. Houghton DE, Alsawas M, Barrioneuvo P, Tello M, Farah W, Beuschel B, Prokop LJ, Layton JB, Murad MH, Moll S. Testosterone therapy and venous thromboembolism: A systematic review and meta-analysis. Thromb Res. 2018 Dec; 172:94-103 Epub 2018 Oct 28
    View PubMed
  66. Mimier MK, Janczak DT, McBane RD, Houghton DE, Wysokinski WE. Thrombosis of atypical location: how to treat patients in the era of direct oral anticoagulants? Pol Arch Intern Med. 2018 Oct 31; 128 (10):604-608 Epub 2018 Sept 20
    View PubMed
  67. Houghton DE, Moll S. Antiphospholipid antibodies. Vasc Med. 2017 Dec; 22 (6):545-550 Epub 2017 Nov 05
    View PubMed
  68. Houghton DE, Sud S, Moll S, Rollins-Raval MA. Perils in the thrombophilia workup: Frequency and circumstances of erroneously ordered factor V activity tests for thrombophilia. Vasc Med 2017 Dec; 22 (6):527-528 Epub 2017 Sept 30
    View PubMed
  69. Houghton DE, Key NS, Zakai NA, Laux JP, Shea TC, Moll S. Analysis of anticoagulation strategies for venous thromboembolism during severe thrombocytopenia in patients with hematologic malignancies: a retrospective cohort. Leuk Lymphoma. 2017 Nov; 58 (11):2573-2581 Epub 2017 Apr 09
    View PubMed
  70. Clark LH, Moll S, Houghton D, O'Connor S, Soper JT. Leukocytosis due to markedly elevated granulocyte-colony stimulating factor levels in a patient with endometrial cancer: Case report and literature review. Gynecol Oncol Rep. 2017 May; 20:5-8 Epub 2017 Jan 22
    View PubMed